Cancer Family
Adnexal Neoplasm
CI-CAN-00000005Explore in graph →
Non-malignant776 active trials5 approved drugs94 evidence items
- NCIt
- C212119
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000005Explore in graph →
Clinical trials
3,521 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06647342 | The Effect of Reduced Bleomycin in Electrochemotherapy Treatment(BLESS) | recruiting | Phase 4 | 55 | Julie GehlOTHER | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07469202 | CYTALUX Dose Extension Study | not yet recruiting | Phase 4 | 106 | On Target Laboratories, LLCINDUSTRY | 0 | Aug 18, 2026 | clinicaltrials |
| NCT06412120 |
| Study Evaluating Safety, Tolerability, and Metabolism of Niraparib |
| recruiting |
| Phase 4 |
| 70 |
| University of MiamiOTHER |
| 2 |
| Aug 5, 2026 |
| clinicaltrials |
| NCT04024254 | A Study of Serum Folate Levels in Patients Treated With Olaparib | completed | Phase 4 | 10 | Rush University Medical CenterOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT07075250 | Safety and Efficacy of RIF Combined With Anlotinib in the Treatment of Patients With Advanced Recurrent Platinum-Resistant Ovarian Cancer: A Prospective, Multicenter Clinical Study(RIFOC003) | not yet recruiting | Phase 4 | 30 | Peking University People's HospitalOTHER | 0 | Jul 20, 2025 | clinicaltrials |
| NCT05294640 | Bacteriostatic Saline as a Local Anesthetic in Minor Eyelid Procedures | completed | Phase 4 | 95 | University of California, San FranciscoOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT01932125 | An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer | completed | Phase 4 | 100 | Hoffmann-La RocheINDUSTRY | 1 | Jun 26, 2025 | clinicaltrials |
| NCT06972693 | NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma(PERSONA-Ovary) | active not recruiting | Phase 4 | 323 | European Institute of OncologyOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06887933 | A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian Cancer | not yet recruiting | Phase 4 | 67 | GlaxoSmithKlineINDUSTRY | 0 | Mar 21, 2025 | clinicaltrials |
| NCT03164980 | QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer(COMPASS) | terminated | Phase 4 | 89 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Mar 20, 2025 | clinicaltrials |
| NCT06871787 | Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery(INOCA) | not yet recruiting | Phase 4 | 50 | Istanbul UniversityOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT04330040 | Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast Cancer(SOLI) | completed | Phase 4 | 202 | AstraZenecaINDUSTRY | 1 | Mar 10, 2025 | clinicaltrials |
| NCT03752216 | NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib.(NiQoLe) | completed | Phase 4 | 141 | ARCAGY/ GINECO GROUPOTHER | 1 | Dec 13, 2024 | clinicaltrials |
| NCT03858166 | Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer | terminated | Phase 4 | 68 | Shandong UniversityOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT05949424 | OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults(OPTI-DOSE) | unknown | Phase 4 | 30 | University Medical Center GroningenOTHER | 1 | Nov 29, 2023 | clinicaltrials |
| NCT05926336 | The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action | unknown | Phase 4 | 1,316 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05606692 | Influences of Propofol and Sevoflurane Anesthesia in Ovarian Cancer (Anesthetics)(anesthetics) | recruiting | Phase 4 | 416 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | May 30, 2023 | clinicaltrials |
| NCT01706120 | Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab(MITO16/MANGO-2) | unknown | Phase 4 | 400 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT04352439 | Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy | completed | Phase 4 | 19 | Duke UniversityOTHER | 1 | Sep 26, 2022 | clinicaltrials |
| NCT00740116 | Tranexamic Acid in Surgery of Advanced Ovarian Cancer | completed | Phase 4 | 100 | Preben Kjolhede, MD, professorOTHER | 1 | Mar 15, 2022 | clinicaltrials |
| NCT05187208 | PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer(POLO) | unknown | Phase 4 | 102 | Seoul National University HospitalOTHER | 0 | Jan 26, 2022 | clinicaltrials |
| NCT01131325 | Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations(MACS1148) | terminated | Phase 4 | 3 | Novartis PharmaceuticalsINDUSTRY | 1 | May 20, 2021 | clinicaltrials |
| NCT01953107 | Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. | completed | Phase 4 | 200 | Sunnybrook Health Sciences CentreOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT03543462 | Diaphragmatic Resection And Gynecological Ovarian Neoplasm(DRAGON) | completed | Phase 4 | 88 | Catholic University of the Sacred HeartOTHER | 1 | May 22, 2020 | clinicaltrials |
| NCT03349463 | Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers. | unknown | Phase 4 | 30 | Bital Savir-BaruchOTHER | 1 | Feb 28, 2020 | clinicaltrials |
| NCT02199327 | Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia | completed | Phase 4 | 18 | Coordinación de Investigación en Salud, MexicoOTHER_GOV | 1 | Aug 8, 2017 | clinicaltrials |
| NCT00727961 | A Study to Evaluate Efficacy and Tolerance of Caelyx in Patients With Epithelial Ovarian Cancer. (Study P04072)(COMPLETED) | completed | Phase 4 | 58 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Jun 8, 2017 | clinicaltrials |
| NCT01432015 | Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting | completed | Phase 4 | 20 | Gynecologic Oncology AssociatesOTHER | 1 | Mar 28, 2017 | clinicaltrials |
| NCT02035345 | Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment | terminated | Phase 4 | 15 | Massachusetts General HospitalOTHER | 1 | Dec 8, 2016 | clinicaltrials |
| NCT00817479 | Tumor Gene Expression in Women With Ovarian Cancer | completed | Phase 4 | 20 | University of ChicagoOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT02243059 | Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer(MILO) | withdrawn | Phase 4 | 0 | Maastricht University Medical CenterOTHER | 1 | Sep 28, 2015 | clinicaltrials |
| NCT00190697 | A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment | completed | Phase 4 | 70 | Eli Lilly and CompanyINDUSTRY | 1 | May 25, 2007 | clinicaltrials |
Data updated 15 days agoSource updated Sep 15, 2026source: clinicaltrials